Your browser doesn't support javascript.
loading
Network Meta-analysis of 10 Kinds of Oral Chinese Patent Medicine Combined with Chemotherapy in Treatment of Gastric Cancer / 中国实验方剂学杂志
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 181-195, 2021.
Article in Chinese | WPRIM | ID: wpr-906222
ABSTRACT

Objective:

To compare the efficacy and safety of 10 kinds of oral Chinese patent medicines combined with chemotherapy in the treatment of gastric cancer in a network Meta-analysis.

Method:

PubMed,Embase,Web of Science,Cochrane Library,CNKI,China biomedical literature service system,VIP,Wanfang database were retrieved to obtain Chinese and English literatures published before March 1,2020. The randomized controlled trials(RCTs) and data were screened and extracted. The quality of the included literatures was also evaluated. The pair-work Meta-analysis was conducted by Revman 5.3 software, and the Meta-analysis were conducted by ADDIS 1.16.7 software.

Result:

A total of 41 randomized controlled trials were eventually involved. All of them were two-arm,including 10 oral Chinese patent medicines,Cinobufotalin,Jinlong capsule,Pingxiao capsule,Shenyi capsule,Xihuang pill (or capsule),Xiaoaiping tablet,Yangzheng Xiaoji capsule,Zhenqi Fuzheng granule combined with chemotherapy for gastric cancer. The effective rate for treating cancer was significantly higher than that of chemotherapy alone (<italic>P</italic><0.05). Zhenqi Fuzheng+chemotherapy was the best choice; the KPS improvement rate of Cinobufacin,Shenyi capsule,Yangzheng Xiaoji capsule,Zhenqi Fuzheng granule combined with chemotherapy in the treatment of gastric cancer was significantly increased(<italic>P</italic><0.05). Shenyi capsule combined with chemotherapy might be the best regimen. The incidence rate of leukocyte decline was significantly lower in the treatment of gastric cancer(<italic>P</italic><0.05). The combination of Zhenqi Fuzheng granule and chemotherapy was the best choice. Traditional Chinese medicine could not reduce the incidence of neurotoxicity(<italic>P></italic>0.05). Cinobufufacin,Yangzheng Xiaoji capsule and Zhenqi Fuzheng granule combined with chemotherapy could increase CD4<sup>+</sup>/CD8<sup>+ </sup>in patients with gastric cancer, which was significantly higher than that of chemotherapy alone(<italic>P</italic><0.05).

Conclusion:

All kinds of oral Chinese patent medicines can play a significantly role in the treatment of gastric cancer. Zhenqi Fuzheng granule,angzheng Xiaoji capsule and Shenyi capsule combined with chemotherapy are more effective in treating gastric cancer.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Controlled clinical trial / Systematic reviews Language: Chinese Journal: Chinese Journal of Experimental Traditional Medical Formulae Year: 2021 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Controlled clinical trial / Systematic reviews Language: Chinese Journal: Chinese Journal of Experimental Traditional Medical Formulae Year: 2021 Type: Article